The Application Value and Strategy of Warfarin in Elderly Patients with Atrial Fibrillation in the Era of Direct Oral Anticoagulants
Abstract：Cohort studies have confirmed that aging, as a continuous variable, acts as a strong driver for stroke occurrence in patients with atrial fibrillation (AF) [1]. The risk and severity of thromboembolism in elderly non-valvular AF patients continue to increase with age. Rational and effective anticoagulant therapy is a necessary and most effective measure for preventing thromboembolic events in elderly AF patients. Whether it is warfarin or direct oral anticoagulants (DOACs), elderly patients can benefit from appropriate anticoagulant therapy [2].
Keywords：Anticoagulants%Atrial Fibrillation%Stroke%Warfarin%Direct Oral Anticoagulants
Publication Date：2025-11-15
Online Publishing Date：2025-12-02(First online date of this platform, not the publication date of the document)
Pages：4( 1445-1448 )